相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DeepEMhancer: a deep learning solution for cryo-EM volume post-processing
Ruben Sanchez-Garcia et al.
COMMUNICATIONS BIOLOGY (2021)
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Eric F. Pettersen et al.
PROTEIN SCIENCE (2021)
JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition
Yiming Luo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells
Caleb R. Glassman et al.
CELL (2021)
The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design
Robert A. Saxton et al.
IMMUNITY (2021)
A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline
Gonzalo Carreno-Tarragona et al.
LEUKEMIA (2021)
Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
Robert A. Saxton et al.
SCIENCE (2021)
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist
Caleb R. Glassman et al.
ELIFE (2021)
3D variability analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM
Ali Punjani et al.
JOURNAL OF STRUCTURAL BIOLOGY (2021)
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
Fei Mo et al.
NATURE (2021)
Highly accurate protein structure prediction for the human proteome
Kathryn Tunyasuvunakool et al.
NATURE (2021)
Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data
Ana Casanal et al.
PROTEIN SCIENCE (2020)
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations
Stephan Wilmes et al.
SCIENCE (2020)
Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction
Ali Punjani et al.
NATURE METHODS (2020)
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
Kritika Mohan et al.
SCIENCE (2019)
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
James R. Burke et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
Dorothee Liebschner et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)
ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps
Tristan Ian Croll
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2018)
Mechanistic insights into Regulation of JAK2 Tyrosine Kinase
Stevan R. Hubbard
FRONTIERS IN ENDOCRINOLOGY (2018)
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation
Ryan D. Ferrao et al.
ELIFE (2018)
Do We Know Jack About JAK? A Closer Look at JAK/STAT Signaling Pathway
Emira Bousoik et al.
FRONTIERS IN ONCOLOGY (2018)
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani et al.
NATURE METHODS (2017)
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions
Ryan Ferrao et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Crystal Structure of a Complex of the Intracellular Domain of Interferon λ Receptor 1 (IFNLR1) and the FERM/SH2 Domains of Human JAK1
Di Zhang et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
The Structural Basis for Class II Cytokine Receptor Recognition by JAK1
Ryan Ferrao et al.
STRUCTURE (2016)
Peptides in headlock - a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy
Michael B. Braun et al.
SCIENTIFIC REPORTS (2016)
Insights into Cytokine-Receptor Interactions from Cytokine Engineering
Jamie B. Spangler et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
Ignacio Moraga et al.
CELL (2015)
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain
John S. Tokarski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The molecular regulation of Janus kinase (JAK) activation
Jeffrey J. Babon et al.
BIOCHEMICAL JOURNAL (2014)
The JH2 domain and SH2-JH2 linker regulate JAK2 activity: A detailed kinetic analysis of wild type and V617F mutant kinase domains
Arturo Sanz Sanz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase
Yibing Shan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Structural basis of recognition of interferon-α receptor by tyrosine kinase 2
Heidi J. A. Wallweber et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition
Patrick J. Lupardus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Andrew J. Brooks et al.
SCIENCE (2014)
Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
Angela V. Toms et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer
John J. O'Shea et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Janus Kinase Deregulation in Leukemia and Lymphoma
Edwin Chen et al.
IMMUNITY (2012)
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
Priya Koppikar et al.
NATURE (2012)
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
Rajintha M. Bandaranayake et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
JAK2 the future: therapeutic strategies for JAK-dependent malignancies
Lindsay M. LaFave et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
The JAK2 exon 12 mutations: A comprehensive review
Linda M. Scott
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors
Claude Haan et al.
CHEMISTRY & BIOLOGY (2011)
Orientation-specific signalling by thrombopoietin receptor dimers
Judith Staerk et al.
EMBO JOURNAL (2011)
Structural Snapshots of Full-Length Jak1, a Transmembrane gp130/IL-6/IL-6Rα Cytokine Receptor Complex, and the Receptor-Jak1 Holocomplex
Patrick J. Lupardus et al.
STRUCTURE (2011)
JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors
Alexandra Dusa et al.
PLOS ONE (2010)
Structural Biology of Shared Cytokine Receptors
Xinquan Wang et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
Neal K. Williams et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex
Georgios Skiniotis et al.
MOLECULAR CELL (2008)
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science
O. Kilpivaara et al.
LEUKEMIA (2008)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
Linda M. Scott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Active conformation of the erythropoietin receptor - Random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains
XH Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation - Cross-talk with IGF1 receptor
J Staerk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Automated electron microscope tomography using robust prediction of specimen movements
DN Mastronarde
JOURNAL OF STRUCTURAL BIOLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction
P Saharinen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
